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The patient with diabetes mellitus who becomes unconscious
presents a problem in differential
diagnosis. We now recognize six
possible causes of coma in the diabetic patient. These include the
usual diabetic keto-acidosis, and
five possible non-ketotic causes:
I. Keto-acidosis
II. Non-ketotic causes of coma
A. Unconsciousness unrelated
to diabetes, e.g. barbiturate
intoxication, "stroke," uremia
B. Hypoglycemia
C. Lactic acidosis
D. Hypernatremia
E. Hyperglycemia
Of the non-ketotic types, the first
may be considered to be a coincidence of unrelated events in a diabetic patient, i.e., diabetes plays no
direct and immediate causal role in
the coma.
Hypoglycemic coma most commonly follows excessive dosage of
insulin, but may also be caused by
the oral hypoglycemic agents, especially in patients with impaired renal
function who do not excrete the
sulfonylureas well. Hypoglycemia
four to five hours after eating also
may be a manifestation of early,
untreated diabetes, with delayed secretion of insulin by the pancreas.
Lactic acidosis results from tissue
hypoxia, with inability to convert
lactate to pyruvate, the accumulation of lactic acid resulting in acidosis. This is most often seen in
patients who have been in prolonged shock, as from slow bleeding or from myocardial infarction.
Often they have an alcoholic history. The prolonged shock with tis6

sue hypoxia causes excessive production of lactic acid, which is not
adequately removed by the liver.
The serum bicarbonate and pH are
down, but no acetone is present in
the urine or in the plasma.
Hypernatremic coma and hyperglycemic coma are both produced
by cellular dehydration resulting
from excessive hyperosmolarity of
the extracellular fluid . Generally in
hypernatremic coma serum sodium
levels are as high as 156 to 188
mEq/ liter. Hyperglycemic coma is
characterized by blood sugar levels
of 600 to 1000 mg% or higher.
Hyperosmolar coma occurs chiefly
in older individuals. Their diabetes
is often of recent onset, with no
treatment or inadequate treatment,
and a slow development of stupor
and unconsciousness. Treatment
consists of the administration of
hypotonic fluids and insulin as
needed. These patients do not have
the extreme resistance to insulin
seen in keto-acidosis, and the
amount of insulin required is usually much less than in keto-acidotic
coma.
In the patient who develops ketoacidosis, a shortage of insulin is the
key defect. This shortage can arise
from a variety of circumstances,
such as undiagnosed, untreated diabetes, omission of insulin in the
known diabetic, or failure to meet
the increasing requirement for insulin caused by infection, inactivity,
or emotional disturbances. We recognize that the key ingredient in
therapy is insulin. However, as the
acidosis develops, there occur a
number of changes in extracellular
and intracellular fluid and electro-

lytes. I would like to spend a little
time discussing these because they
represent important facets of this
disturbance.
FLUID AND ELECTROLYTE
DISTURBANCES

Depletion of Cell Potassium
Patients who develop keto-acidosis usually have anorexia and
vomiting. Obviously, anything that
interferes with the intake of food
and fluids will interfere with the
intake of potassium, so that the
ordinary supply of potassium is cut
off. At the same time, the interruption of glycolysis, a source of energy for maintenance of the intracellular distribution of potassium,
results in a leaking out of potassium
from the cells. Also, because patients with keto-acidosis are not
eating, they will have a negative
nitrogen balance. Cell protein is
ordinarily laid down in a proportion of lg of nitrogen to 3 mEq of
potassium. When a negative nitrogen balance occurs, potassium is
lost from the cells. Also, the patient
in diabetic keto-acidosis is not storing carbohydrate in the liver as
glycogen. This process ordinarily
removes from the extracellular fluid
a certain amount of potassium. As
the liver becomes deglycogenated in
the keto-acidotic patient, this potassium is released. So we now have
three processes transferring potassium from the cells into the extracellular fluid; loss of the pump effect, negative nitrogen balance, and
deglycogenation of the liver.
The so-called "dehydration reaction" is a fourth cause of potasMCV QUARTERLY 2(1): 6-9, 1966
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sium loss from cells. These patients become dehydrated, first of
all because they are not taking
fluids. At the same time, they usually have an osmotic diuresis and
continue to lose fluids from the skin
and through the lungs. As dehydration progresses, the body tries to
maintain the integrity of the extracellular and intracellular fluid as
close to normal as possible. Most of
the losses are from the extracellular
fluid in the initial phase, but ultimately transfers from cells to extracellular fluid occur. A variety of
mechanisms bring these transfers
about. First, as the tonicity of the
extracellular fluid rises because of
hyperglycemia, water is drawn out
of the cells. Secondly, there is a dehydration reaction which permits
the release of potassium from cells
and with it a modicum of water. In
other words, the transfer of potassium out of the cells reduces the
osmolarity of the cells and raises
the osmolarity of the extracellular
fluid, and therefore water is transferred with the potassium. These
mechanisms serve to prevent excessive depletion of extracellular fluid,
but at the same time they deprive
the cells further of potassium.
That a deficit of cell potassium
of sufficient degree produces histologic evidence of cell destruction is
clearly demonstrable in heart and
skeletal muscle. Interference with
normal cell function by potassium
depletion is recognized in electrocardiographic changes, and in altered function of the nervous system, the gastrointestinal tract, and
the kidneys. But more important
than any of these is that potassium
deficits within the cell are associated with increased mortality. This
is amply demonstrated in animal
studies and has its counterpart in
the clinical situation.

Serum Potassium Levels
Although the patient with diabetic keto-acidosis is markedly depleted of potassium, the initial
level of serum potassium is often
high. This is because, during the

development of keto-acidosis, potassium has been transferred from
cells into the extracellular fluid,
and as dehydration and decreased
renal blood flow diminish the urine
output, potassium may not be well
excreted. With fluid replacement
and insulin treatment, potassium
will quickly re-enter the cells and
the serum potassium may drop
sharply during the first few hours
of treatment. In children, the initial serum potassium levels are not
so often elevated, but may be normal or occasionally low. The reason may be that in children there
is possibly a greater osmotic diuresis
and a more rapid excretion of the
potassium that has passed from the
cells into extracellular fluid. In
either case a low initial serum potassium level should alert one to
the presence of very severe potassium depletion and the danger of
severe hypokalemia developing in
the course of treatment.

Sodium Loss, Dehydration,
and Shock
With respect to sodium, some of
the comments already made concerning potassium apply. The intake
of this electrolyte is cut off, and
further losses occur through vomiting and from renal loss as part of
the osmotic diuresis. All these
losses of sodium result in sodium
depletion. When extracellular sodium is reduced by 25 % a prompt
decrease in circulatory efficiency
occurs. If sodium is lost from extracellular fluid in excess of water,
hypo-osmolarity of the extracellular fluid results. This causes water
to move into the cells. This by itself has no particular significance,
but the loss of circulating volume
from the extracellular fluid, either
by loss to the exterior or by transfer into cells, results in circulatory
inefficiency. With the reduction in
plasma volume the hematocrit rises.
There is slowing of the circulation,
with diminished venous return, decreased cardiac output and increased peripheral resistance. The
end result is circulatory collapse,

just as real as that which can follow hemorrhage, extensive trauma,
or any other cause.
It is very important to recognize
the occurrence of sodium deficits.
Such deficits are invariably present
but the signs of circulatory collapse
may not be. I think surely all of
us now realize that we can have
circulatory inefficiency with a normal blood pressure. As the blood
volume falls, the blood pressure
can be maintained for a while by
arteriolar constriction, but this will
lessen the delivery of blood to the
tissues, which in turn interferes
with cell function.
THERAPY

Insulin
The treatment of diabetic ketoacidosis begins with insulin. Generally this can be given in the home
before the patient is referred to the
hospital. Time is of the essence and
one has to make sure that valuable
time is not lost transporting the patient to the hospital, getting him
admitted, finding out about hospital
insurance, etc., and moving him to
his bed. How much insulin, what
route of administration, frequency
of dosage etc., you and I could discuss for a long time. I think it is
interesting to recall that some 20
years ago, Rabinowitz, in Montreal,
routinely administered 200 units of
insulin on admission and gave no
further insulin, and in that particular series of patients all of them
recovered. You and I are more apt
to approach this problem in a
gradual fashion, so to speak. We
back into a final decision. Of course
we can be a little bit more scientific if we call it "the method of
successive approximations toward
the need," but fundamentally
"chicken" is a better term. I think
it is better to remember that you
can quite safely give too much insulin because you can counteract
this subsequently by administering
carbohydrate. But if you do not
give enough insulin, the one thing
that you cannot recapture is time.
So, if you are going to make a mis7
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take, do so in a very bold fashion.
Experience indicates that ordinarily
300 or 500 units of insulin in the
first 24 hours have proved to be
adequate. This does not mean that
there are not going to be patients
that require a good deal more. Also
you will have patients who will do
well on a smaller quantity. This is
an average figure and ordinarily in
this "chicken" fashion, you will first
administer 100 units as soon as the
patient comes into the emergency
room. This gives you a chance to
get a little information as to the
level of blood sugar, the decrease
in "C02," the presence of plasma
acetone, and the status of the circulation.

Fluids
After withdrawing blood from
one vein, you start an infusion of
0.9% sodium chloride solution.
There are many choices of solutions. We still prefer sodium
chloride. First it is generally available. Secondly, all of the solutions
that are offered represent confusion
in a sense. If you use Ringer's lactate solution, it has a little bit of
bicarbonate in it and it has a little
bit of potassium and you may think
you are doing something, but you
are only deluding yourself. So we
recommend beginning fluid replacement with sodium chloride. It is a
useful rule of thumb to keep in
mind that an adult diabetic coma
patient comes in with a water deficit equal to 10% of the body weight,
a sodium deficit of 10 mEq/ kg, a
chloride deficit of 10 mEqjkg, and
a potassium deficit of 5mEq/kg.
This means that in an adult weighing 70 kg, on admission there is a
deficit of 7 liters of water, 700
mEq of sodium, 700 mEq of chloride, and 350 mEq of potassium.
Our goal is not to replace these
deficits at once. Our goal is one of
turning the patient around and
starting him toward recovery and
away from death. The administration of sodium chloride following
the initial dose of insulin provides
an adequate beginning in most in8

stances. Ordinarily it will be sufficient to give two liters of sodium
chloride, which contains approximately 18 g, or 308 mEq of sodium
and of chloride. Please note that
we are not trying to replace the total deficit of 700 mEq at once. We
are giving part of it over the course
of several hours. We recognize that
during these several hours some of
what we have administered will continue to be lost in the urine or by
other routes. But it is enough just
to turn the patient around. At the
end of the 2 liters of saline, which
will probably take some 3 hours to
administer, one will have further
laboratory data. At that point it
may very well be that the laboratory indicates that the serum potassium is now down to normal or below normal, and at this point one
can start therapy with potassium.
Also laboratory reports will often
indicate that the blood sugar is decreasing. At this point the potassium can be administered in 5 %
glucose. Generally it is desirable to
use potassium phosphate rather
than chloride. The reason for this
is that we are using sodium chloride which has 154 mEq of chloride which is higher than the
concentration normally present in
extracellular fluid. We do not want
to give KC! because we will be further adding to the chloride load
and in some patients a hyperchloremic acidosis may result. The
second reason is that patients with
diabetic keto-acidosis develop deficits of phosphate from lack of intake and from Joss of this solute in
the urine. This phosphate does not
come from the extracellular fluid;
it comes from the cells. Some of it
comes from protein breakdown, but
the majority of it represents the
breakdown of high-energy phosphate compounds such as ATP and
creatine phosphate which are not
being rebuilt because carbohydrate
metabolism is reduced. No one has
ever succeeded in demonstrating
that these huge deficits of phosphate do any harm. Nonetheless, it
does seem logical to give the potassium replacement as buffered phos-

phate, both to help somewhat in replacement of phosphate, and to
avoid adding to the chloride load.
How much potassium would you
give? If the total deficit is estimated
to be 350 mEq, it would probably
be enough to set as a goal the administration of approximately one
third of that over 3 or 4 hours, at
the rate of approximately 40 mEq
per hour.

Glucose
There has been great controversy
in the past as to whether glucose
should be given in the initial phase
of treatment. Glucose solutions
given even at the start of treatment
do no harm except possibly to contribute further to the osmotic diuresis. Glucose does help to replete
liver glycogen and diminish the
ketosis, but many prefer not to begin glucose administration until
there is definite evidence that the
blood sugar has begun to fall with
treatment. We should remember
that even an initial blood sugar of
500 mg% may not represent more
than 50 or 60 g of total glucose in
the extracellular fluid, and this
amount can be put back into cells
fairly quickly once enough insulin
is given. It is imperative that glucose be provided as the blood sugar
falls, in amounts adequate to cover
the large doses of insulin that have
been given, and at a rate rapid
enough to prevent hypoglycemia.

Dextran and Alkalis
It is a good rule in seriously ill
patients to consider two additional
elements in the early therapy. The
first of these is the use of dextran,
or less desirably, the use of whole
blood or plasma. Whole blood or
plasma is less desirable because of
the problem of hepatitis. In patients
on the verge of circulatory collapse
or in actual circulatory collapse, a
unit of dextran is a kind of insurance and I would rather give it
needlessly to 99 patients than fail
to give it to the one who needs it.
The second item is the use of alkali
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solutions shortly after admission.
I like to reserve these for patients
who have a reduction of the pH
down to seven or so. The routine
administration of alkali interferes
with the use of "C02" (bicarbonate)
as a precise index of improvement.
It is very reassuring to find that a
bicarbonate of 5 mEq/liter has risen
after several hours of treatment to
8 or 9 mEq/liter. I know that the
patient is clearing ketone bodies
and is responding to insulin. I cannot tell this quite as precisely when
one uses the plasma acetone or the
urine acetone as the sole index.
This index is lost when 6 molar lactate or sodium bicarbonate is administered. On the other hand if
the pH is reduced sufficiently, we
know that this by itself threatens
survival, and under these circumstances one should give alkali.

Use of Fructose
Another point that deserves mention is the use of fructose instead
of glucose. Theoretically there are
several advantages to fructose . First
of all , it can enter the glycolytic
cycle without the intervention of
insulin. Secondly, it is an excellent
glycogen former and, as we have
indicated, hepatic glycogen is depleted. Thirdly, the Tm for glucose
and the Tm for fructose are independent and non-additive. The kidneys reabsorb glucose and fructose
independently, and therefore one
can carry higher blood sugar levels
with less glycosuria. All of these
are cogent arguments, but from the
practical point of view, they are
not significant. Fructose further
complicates therapy and there may
be some hazard because in children
fructose causes massive deposition
of glycogen in the liver which itself
might be harmful. The liver becomes greatly distended and you
have the feeling that only the capsule is preventing it from bursting.
I have said nothing about lavage
of the stomach or passage of a
stomach tube. Life is already complex when you have a keto-acidotic
patient to look after, and passing a

tube into an unconscious patient is
not the easiest thing to do. The
stomach tube should be put down
only in those patients who continue
to vomit. Most patients will not
continue vomiting if you do not
give anything by mouth. Whatever
is in the stomach and gastrointestinal tract will be absorbed as therapy
continues, so generally it is reasonable to avoid this additional complication.
MANAGEMENT AFTER THE
FIRST FEW HOURS

hypoglycemic range. Approximately
20 % develop hypokalemia with potassium levels below 3.5 or 3.0
mEq/ liter. These are the two sequelae which undoubtedly account
for unexplained deaths in comas
that have been otherwise treated
very successfully. When the patient
reaches the 24th hour of treatment,
usually we put him back on his usual dosage of insulin or on regular
insulin. With resumption of a normal dietary intake, the remaining
deficits are made up.
MORTALITY

We have come now to the sixth,
seventh or eighth hour and the patient is responding to treatment in
a satisfactory fashion. We have seen
some decrease in the blood sugar,
some rise in the "C02," some decrease in the acetonemia. The urine
continues to contain sugar; it still
contains ketone bodies but perhaps
in reduced quantities. By this time
the patient is partially restored to
consciousness, perhaps asking for
food and fluids by mouth. We can
begin to relax a little, but we should
not take the needle out of the vein.
The patient can be started at this
point on some intake by mouth. If
vomiting ensues, this should be discontinued. One can alternate tea
fortified with glucose and sucrose
and lactose with 0.5 % sodium chloride broth. The real problem is encountered between the 12th and
24th hour. The difficulties stem
from the fact that the house staff
has been working all night long on
the coma patient; morning arrives,
and it is time to have the report
and to make rounds. So everyone
relaxes as far as attention to the patient goes. Or, if the house staff has
worked all day, it is midnight and
time to go to bed. The nurses are
very considerate, so they do not report promptly when the glucose infusion is not working properly.
There are two problems that develop. One is hypoglycemia and the
other is hypokalemia. Twenty percent of the patients who are in the
12th to 24th hour of therapy develop blood sugars which are in the

There is no question that some
centers have a better record than
others. Certainly the Joslin Clinic
record is most impressive with mortalities of 1 % , 2 % , or 3 % . It is
recognized that these low mortality
rates represent a very selected type
of experience, under unusually favorable circumstances. The Joslin
Clinic has a laboratory that is set
up to look after keto-acidosis seven
days a week. Unfortunately, in
many other centers the mortality
is still high. It ranges between 15 %
and 25% in adults. The mortality
in pediatric diabetic coma is much
less. Indeed, you hardly ever see a
death in childhood provided the
diabetes had been recognized previously, the patient is under therapy,
and the coma is treated in a qualified institution. But there are still
deaths in children which result from
previously undiagnosed diabetes
terminating in coma, or that result
from the assumption that all hospitals are equivalent in terms of their
ability to treat diabetic keto-acidotic
coma. Properly treated, keto-acidosis in children and adults should be
nothing but an event, certainly an
avoidable event in many cases, in
the life of the diabetic.
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